Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Jan 3rd Share Repurchase… 2,999,497

<< Previous

Bullboard Posts

Next >>

Comment by luscar99on Jan 20, 2024 2:09pm

97 Views

Post# 35837444

RE:RE:Jan 3rd Share Repurchase… 2,999,497

As of January 1st there were only 163761 shares left to buy under the current NCIB (expiring in July).
If they continued the buybacks in January we're just about done.

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for June 3, 2024